BSECompany Update26 Sept 2026 · 26 Sept 2026, 08:36 pm
Re-appointment of Managing Director
Ganga Pharmaceuticals Ltd · 539680
✦ AI SummaryMgmt Change
Ganga Pharmaceuticals Ltd has announced the re-appointment of Mr. Bharat Brijmohan Sharma as Managing Director for a further period of three years effective from April 01, 2026. The re-appointment was approved by the Members of the Company at the 37th Annual General Meeting held on September 26, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Ganga Pharmaceuticals Ltd - 539680 - Announcement under Regulation 30 (LODR)-Change in Directorate
Attachments (1)
📄pdf
Download →
79e20ffd-1bf0-4062-b23f-6b0acc89c5c7.pdf
View document text
Ganga Pharmaceuticals Limited
CIN: L99999MH1989PLC053392
Regd. Office: Gangatat, Dhanvantri Marg, Gopcharpada, Virar (E), Palghar - 401305
Phone: 9834613142 |Website: www.ayurvedganga.com | Email: ayurvedganga@gmail.com
September 26, 2026
BSE Limited,
Phiroze Jeejeebhoy Towers,
Dalal Street, Fort,
Mumbai – 400 051
Scrip Code: 539680
Sub: Intimation pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015 (“SEBI Listing Regulations”) – Re-appointment of Managing
Director
Dear Sir/Madam,
Pursuant to Regulation 30 of the SEBI Listing Regulations, and based on the results declared at the 37th
Annual General Meeting of the Members of the Company held on Saturday, September 26, 2026, please take note
that the Members of the Company have approved the re-appointment of Mr. Bharat Brijmohan Sharma
(DIN: 00077026) as Managing Director for a further period of three years effective from April 01, 2026,
not liable to retire by rotation.
Kindly take note that Mr. Bharat Brijmohan Sharma is not debarred from holding the office of Director
by virtue of any SEBI order or order of any other such Authority.
Disclosure under Regulation 30 of the SEBI Listing Regulations read with SEBI Circular no.
HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 is annexed herewith.
The above information is also available on the website of the Company i.e., www.ayurvedganga.com.
The Annual General Meeting commenced at 4:30 p.m. and concluded at 5:00 p.m.
Kindly take the same on record.
Thanking You,
Yours faithfully,
For Ganga Pharmaceuticals Limited
Bharat Sharma
Managing Director
DIN: 00077026
Encl: As above
Ganga Pharmaceuticals Limited
CIN: L99999MH1989PLC053392
Regd. Office: Gangatat, Dhanvantri Marg, Gopcharpada, Virar (E), Palghar - 401305
Phone: 9834613142 |Website: www.ayurvedganga.com | Email: ayurvedganga@gmail.com
Annexure
Disclosure under Regulation 30 of the SEBI Listing Regulations read with SEBI Circular no.
HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026
Sr. Particulars Details
1 Reason for change viz. appointment, Re-appointment
re-appointment, resignation, removal,
death or otherwise;
2 Date of appointment/cessation (as Re-appointment of Mr. Bharat Brijmohan Sharma
applicable) and terms of appointment (DIN: 00077026) as Managing Director for a further
period of three years effective from April 01, 2026,
not liable to retire by rotation
3 Brief Profile (in case of appointment) Mr. Bharat Brijmohan Sharma possesses over 35
years of experience in Business and Pharma
Industry.
4 Disclosure of relationships between Mrs. Bharat B. Sharma is spouse of Mrs. Srijna
Directors Sharma, Whole-time Director of the Company.